There was no evidence of GvHD in an NSG mouse model of leukemia treated with the PEBL-CD19-CAR T cells, whereas 60% of the mice treated with CAR T cells that were not expressing the CD3ε PEBL developed GvHD. The gene discussed is CD19; the disease is leukemia.